跳至主要内容
临床试验/NL-OMON51683
NL-OMON51683尚未招募不适用

Promoting immune health by intermittent fasting: a pilot study - TIGER

Amsterdam UMC0 个研究点目标入组 24 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • the at-risk group:
  • Body mass index (BMI) 30 to 43 kg/m2)
  • HOMA-IR index of >= 2.5 (measured as fasting insulin (pmol/L) x fasting
  • glucose (mmol/L)) / 135)
  • At least 3 out of 5 NCEP metabolic syndrome criteria
  • Healthy group
  • Body mass index (BMI) 18 to 25 kg/m2,
  • Waist circumference between 79 cm and 94 cm,
  • HOMA-IR index <= 2.0

排除标准

  • - Excessive weight loss of >10% in the last months;
  • - Use of any medication
  • - Pregnant, trying to get pregnant or breast feeding at inclusion;
  • - Irregular menstrual cycle;
  • - Hormonal replacement therapy.
  • - Cholecystectomy;
  • - Untreated GI disease/abnormal bowel habits;
  • - A history of cardiovascular event (MI or pacemaker implantation)

研究者

发起方
Amsterdam UMC

相似试验